Varian Medical Systems, Inc. (NYSE:VAR)
February 13th, 2019
With markets going up Varian Medical Systems, Inc. finished Wednesday’s trading session down 0.11%, a ($0.14) decrease to close on $132.72. Despite the drop in price it hit a new 52 week high of $133.41.
Varian Medical Systems, Inc. is listed on the S&P 500 index, and was one of 161 stocks that slumped today. Weighted by market cap, VAR represents about 0.05% of the S&P 500.
Analysis results from 8 analysts points to the possibility that Varian Medical Systems, Inc. could increase somewhat (2.71%), while Finbox has calculated (with low uncertainty) a fair value price of $137.07.
The market sectors were mixed Wednesday with a majority of the sectors trending up. Energy saw the biggest increase of the day (1.29%), while Utilities saw the biggest drop (-0.31%). Industrials has seen the biggest year-to-date gain at 15.68%.
Energy saw the biggest turnaround from its 5-day performance of -1.99%, as it went up 1.29%. Utilities saw a turn around from its 5-day performance of 1.76% trading down -0.31%.
- Energy went up with a 1.29% change.
- Industrials went up with a 0.63% change.
- Consumer Discretionary went up with a 0.62% change.
- Real Estate went up with a 0.58% change.
- Consumer Staples went up with a 0.25% change.
- Healthcare went up with a 0.25% change.
- Financials went up with a 0.20% change.
- Information Technology went up with a 0.14% change.
- Materials went up with a 0.10% change.
- Communication Services went down with a -0.10% change.
- Utilities went down with a -0.31% change.
Varian Medical Systems, Inc. Info
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
All amounts in USD unless otherwise indicated
Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.